TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35579583

Group type: EXPERIMENTAL
Intervention: Fluoride-releasing sealant (Helioseal® F)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Fluoride varnish (Duraphat®)
Number of subjects: 44
Study: 33276125

Group type: EXPERIMENTAL
Intervention: IUD use
Number of subjects: 1350

Group type: COMPARATOR
Intervention: No IUD use (otherwise)
Number of subjects: 1350

Group type: EXPERIMENTAL
Intervention: Multiple partners at baseline
Number of subjects: 1350
Study: 32171064

Group type: EXPERIMENTAL
Intervention: Maintenance budesonide (200 μg twice per day) plus as-needed salbutamol (two inhalations of 100 μg)
Number of subjects: 675

Group type: COMPARATOR
Intervention: As-needed salbutamol (two inhalations of 100 μg)
Number of subjects: 675

Group type: EXPERIMENTAL
Intervention: As-needed budesonide-formoterol (one inhalation of 200 μg budesonide and 6μg formoterol)
Number of subjects: 675
Study: 35074887

Group type: EXPERIMENTAL
Intervention: Group-administered recovery programme (3 sessions, 2 weeks apart)
Number of subjects: 207

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 207
Study: 32650047

Group type: EXPERIMENTAL
Intervention: Financial difficulty
Number of subjects: 451

Group type: EXPERIMENTAL
Intervention: Multiple hardships
Number of subjects: 451

Group type: EXPERIMENTAL
Intervention: Housing disrepair
Number of subjects: 451

Group type: EXPERIMENTAL
Intervention: Suboptimal sleep practices
Number of subjects: 451

Group type: EXPERIMENTAL
Intervention: Suboptimal sleep practices in infancy
Number of subjects: 451
Study: 34261997

Group type: EXPERIMENTAL
Intervention: Commercial wrist‐worn activity tracker (Polar Loop 2; Polar, Kempele, Finland) worn for 12 months
Number of subjects: 231

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 231
Study: 34312316

Group type: EXPERIMENTAL
Intervention: TERECO (telerehabilitation programme)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control (no rehabilitation)
Number of subjects: 120
Study: 33038833

Group type: EXPERIMENTAL
Intervention: DHA (50 mg/Kg/day)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: DHA
Number of subjects: 96
Study: 32871950

Group type: EXPERIMENTAL
Intervention: Conbercept 6-monthly loading dose injection and PRN (6+PRN)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conbercept 3-monthly loading dose injection and PRN (3+PRN)
Number of subjects: 0
Study: 36031597

Group type: EXPERIMENTAL
Intervention: Intense pulsed light therapy
Number of subjects: 122
Study: 32064906

Group type: EXPERIMENTAL
Intervention: Pharmacogenetic tests
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Pharmacogenetic tests supported by randomized controlled trials
Number of subjects: 13
Study: 35502861

Group type: EXPERIMENTAL
Intervention: Cold Acclimation (CA) - immersion to the chest in 14°C water for ≥120 min daily over a 5-day period
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Cold Acclimation (CA)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control (CON) - instructed to avoid any cold exposure during the 5-day period
Number of subjects: 14
Study: 34391917

Group type: EXPERIMENTAL
Intervention: Lidocaine (L group)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (D group)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Lidocaine-Dexmedetomidine (LD group)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 24
Study: 35460249

Group type: EXPERIMENTAL
Intervention: Cholecalciferol (vitamin D3) supplementation (weekly 50,000 IU for 4 weeks followed by daily 2000 IU until 1 year)
Number of subjects: 4000

Group type: EXPERIMENTAL
Intervention: Cholecalciferol (vitamin D3) supplementation
Number of subjects: 4000

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4000
Study: 33763741

Group type: EXPERIMENTAL
Intervention: Continuous local anaesthetic wound infusion
Number of subjects: 38

Group type: COMPARATOR
Intervention: Thoracic epidural analgesia
Number of subjects: 38
Study: 32198802

Group type: EXPERIMENTAL
Intervention: IRL752
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 36069038

Group type: EXPERIMENTAL
Intervention: Positive expectation instructional set during pain-inducing massage
Number of subjects: 56

Group type: COMPARATOR
Intervention: Negative expectation instructional set during pain-inducing massage
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Pain-free massage with positive expectation
Number of subjects: 56

Group type: COMPARATOR
Intervention: Pain-free massage with negative expectation
Number of subjects: 56
Study: 32633172

Group type: EXPERIMENTAL
Intervention: Healthcare professionals (speech and language therapists, neurologists)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Naïve listeners (general population, PD relatives, PD patients)
Number of subjects: 10
Study: 32056444

Group type: EXPERIMENTAL
Intervention: No protocol (rounds 1;2)
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: Protocol A (rounds 3;4)
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: Protocol B (rounds 3;4)
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: No protocol to Protocol B (urologists)
Number of subjects: 155
Study: 33776935

Group type: EXPERIMENTAL
Intervention: Motivational Interviewing + Standard Education (MI+SE)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Standard Education (SE) only
Number of subjects: 47
Study: 32144911

Group type: EXPERIMENTAL
Intervention: Acupoint thread-embedding therapy at 7-day intervals (Treatment Group 1)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Acupoint thread-embedding therapy at 14-day intervals (Treatment Group 2)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Comparison between Treatment Group 1 and Treatment Group 2
Number of subjects: 70
Study: 34384793

Group type: EXPERIMENTAL
Intervention: C‐MAC
Number of subjects: 50

Group type: COMPARATOR
Intervention: Airtraq
Number of subjects: 50
Study: 34843437

Group type: EXPERIMENTAL
Intervention: WISE COACH (WC) video
Number of subjects: 1200

Group type: COMPARATOR
Intervention: Control video
Number of subjects: 1200
Study: 34329456

Group type: EXPERIMENTAL
Intervention: Recreational therapy program (3 sessions a week for 2 weeks)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Routine daily activities
Number of subjects: 58
Study: 34207484

Group type: EXPERIMENTAL
Intervention: Alpha-Glycerylphosphorylcholine (αGPC)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study: 32096282

Group type: EXPERIMENTAL
Intervention: Masked continuous glucose monitoring for up to 14 days
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: Masked continuous glucose monitoring
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: Continuous glucose monitoring metrics
Number of subjects: 143
Study: 35634828

Group type: EXPERIMENTAL
Intervention: Supervised group exercise intervention (12 weeks, 2 days/week, 50-minute sessions)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 67
Study: 33021118

Group type: EXPERIMENTAL
Intervention: Counseling sessions with fidelity monitoring using audio recordings
Number of subjects: 1238

Group type: COMPARATOR
Intervention: Counseling sessions without fidelity monitoring (implied control)
Number of subjects: 1238
Study: 34725668

Group type: EXPERIMENTAL
Intervention: Walking group (n=31)
Number of subjects: 168

Group type: COMPARATOR
Intervention: Interpersonal interaction group (n=31)
Number of subjects: 168

Group type: COMPARATOR
Intervention: Care-as-usual control group (n=29)
Number of subjects: 168
Study: 34547450

Group type: EXPERIMENTAL
Intervention: Roux-en-Y gastric bypass (RYGB)
Number of subjects: 113

Group type: COMPARATOR
Intervention: Medical therapy (MT)
Number of subjects: 113
Study: 33034357

Group type: EXPERIMENTAL
Intervention: SMILE
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: LASIK
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 5.5 years group (both SMILE and LASIK)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: High myopic treatment with LASIK
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Dry eye parameters
Number of subjects: 24
Study: 36451496

Group type: EXPERIMENTAL
Intervention: Combined epidural-general anesthesia
Number of subjects: 347

Group type: EXPERIMENTAL
Intervention: Epidural anesthesia
Number of subjects: 347

Group type: COMPARATOR
Intervention: General anesthesia alone
Number of subjects: 347
Study: 33829717

Group type: EXPERIMENTAL
Intervention: Thulium laser
Number of subjects: 76

Group type: COMPARATOR
Intervention: Stapler
Number of subjects: 76
Study: 33761459

Group type: EXPERIMENTAL
Intervention: Photobiomodulation (PBM) 420 J
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control (C)
Number of subjects: 15
Study: 32163837

Group type: EXPERIMENTAL
Intervention: SSRI
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 33684015

Group type: EXPERIMENTAL
Intervention: Manual therapy (upper limb fascial therapy, 50 min weekly session for three weeks)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 69
Study: 33813850

Group type: EXPERIMENTAL
Intervention: Systolic BP target of <120 mm Hg
Number of subjects: 9361

Group type: COMPARATOR
Intervention: Systolic BP target of <140 mm Hg
Number of subjects: 9361

Group type: EXPERIMENTAL
Intervention: Intensive BP treatment
Number of subjects: 9361
Study: 33765667

Group type: EXPERIMENTAL
Intervention: SnF2 dentifrice B (0.454% SnF2 + sodium hexametaphosphate)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: SnF2 dentifrice C (0.454% SnF2 + citrate)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: SnF2 dentifrice D (experimental 0.454% SnF2 with increased bioavailable Sn)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: SnF2 dentifrice E (0.454% SnF2 + 0.078% NaF + sodium hexametaphosphate)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: SnF2 dentifrice F (0.454% SnF2 + 0.078% NaF + citrate)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Negative Control (NC: 0.1% NaF + 0.76% sodium monofluorophosphate)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Zn/Arg dentifrice (NaF + zinc + arginine)
Number of subjects: 32
Study: 32415802

Group type: EXPERIMENTAL
Intervention: Canagliflozin 100 mg daily for 12 weeks
Number of subjects: 36

Group type: COMPARATOR
Intervention: Sitagliptin 100 mg daily for 12 weeks
Number of subjects: 36
Study: 35533200

Group type: EXPERIMENTAL
Intervention: 40 mg of the noradrenaline reuptake inhibitor atomoxetine
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 34702422

Group type: EXPERIMENTAL
Intervention: Unmanned Aerial Vehicle (UAV) technology
Number of subjects: 47

Group type: COMPARATOR
Intervention: Standard Practice (SP)
Number of subjects: 47
Study: 34546428

Group type: EXPERIMENTAL
Intervention: Self-expanding valves (SE)
Number of subjects: 17295
Study: 33131470

Group type: EXPERIMENTAL
Intervention: Colchicine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ruxolitinib
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Secukinumab
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Proactive anti-inflammatory therapy combined with anticoagulation
Number of subjects: 0
Study: 34098038

Group type: EXPERIMENTAL
Intervention: Facebook social media campaign
Number of subjects: 23
Study: 33228562

Group type: EXPERIMENTAL
Intervention: Pharmacist-led intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study: 616381698

Group type: EXPERIMENTAL
Intervention: Saxagliptin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Major cardiovascular events
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Myocardial infarction
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Stroke
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hospitalization for heart failure
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hospitalization for hypoglycemia
Number of subjects: 0
Study: 33486130

Group type: EXPERIMENTAL
Intervention: MAST MMPR
Number of subjects: 1561

Group type: COMPARATOR
Intervention: Original MMPR
Number of subjects: 1561

Group type: EXPERIMENTAL
Intervention: Both MMPRs
Number of subjects: 1561
Study: 36453766

Group type: EXPERIMENTAL
Intervention: Acute aerobic exercise session (AAES)
Number of subjects: 32
Study: 33284342

Group type: EXPERIMENTAL
Intervention: Commercially available plasmalike isotonic fluids
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 35268539

Group type: EXPERIMENTAL
Intervention: Multidomain intervention (diet, exercise, cognitive training, and vascular/metabolic risk monitoring)
Number of subjects: 1260

Group type: COMPARATOR
Intervention: Regular health advice (control group)
Number of subjects: 1260

Group type: EXPERIMENTAL
Intervention: Multidomain intervention
Number of subjects: 1260

Group type: EXPERIMENTAL
Intervention: Baseline Zung score
Number of subjects: 1260

Group type: EXPERIMENTAL
Intervention: Change in Zung score
Number of subjects: 1260
Study: 32886212

Group type: EXPERIMENTAL
Intervention: Active Surveillance (AS)
Number of subjects: 459

Group type: COMPARATOR
Intervention: External-Beam Radiotherapy (EBRT)
Number of subjects: 459

Group type: COMPARATOR
Intervention: Brachytherapy by Permanent Seed Implantation (PSI)
Number of subjects: 459

Group type: COMPARATOR
Intervention: Radical Prostatectomy (RP)
Number of subjects: 459
Study: 35803757

Group type: EXPERIMENTAL
Intervention: Dexamethasone 8 mg intravenously after induction of anaesthesia
Number of subjects: 1466

Group type: COMPARATOR
Intervention: Placebo intravenously after induction of anaesthesia
Number of subjects: 1466
Study: 33128492

Group type: EXPERIMENTAL
Intervention: Propranolol 1% cream
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Timolol 0.5% cream
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo cream
Number of subjects: 30
Study: 34819721

Group type: EXPERIMENTAL
Intervention: Remimazolam Tosilate (RT)
Number of subjects: 260

Group type: COMPARATOR
Intervention: Etomidate-Propofol (EP)
Number of subjects: 260

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 260
Study: 36377169

Group type: EXPERIMENTAL
Intervention: Pregabalin
Number of subjects: 90

Group type: COMPARATOR
Intervention: Gabapentin
Number of subjects: 90
Study: 35554601

Group type: EXPERIMENTAL
Intervention: Abdominal massage plus lifestyle advice
Number of subjects: 74

Group type: COMPARATOR
Intervention: Placebo therapeutic ultrasound plus lifestyle advice
Number of subjects: 74
Study: 33904521

Group type: EXPERIMENTAL
Intervention: Eplerenone
Number of subjects: 105

Group type: COMPARATOR
Intervention: Amlodipine
Number of subjects: 105
Study: 32343642

Group type: EXPERIMENTAL
Intervention: I/T/DIN/GM-CSF (irinotecan, temozolomide, dinutuximab, and GM-CSF)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: I/T/DIN/GM-CSF
Number of subjects: 53
Study: 35183878

Group type: EXPERIMENTAL
Intervention: Exercise plus biofeedback
Number of subjects: 24

Group type: COMPARATOR
Intervention: Therapeutic exercise
Number of subjects: 24
Study: 32006758

Group type: EXPERIMENTAL
Intervention: Diabetic patients undergoing PCI
Number of subjects: 15957

Group type: COMPARATOR
Intervention: Non-diabetic patients undergoing PCI
Number of subjects: 15957

Group type: COMPARATOR
Intervention: Antiplatelet strategy (experimental versus reference)
Number of subjects: 15957
Study: 34864993

Group type: EXPERIMENTAL
Intervention: Endometrial scratch prior to the second IVF/ICSI treatment
Number of subjects: 933

Group type: COMPARATOR
Intervention: No scratch (control group)
Number of subjects: 933
Study: 32246489

Group type: EXPERIMENTAL
Intervention: Periodontitis
Number of subjects: 826

Group type: COMPARATOR
Intervention: Normal respiratory function
Number of subjects: 826
Study: 36399215

Group type: EXPERIMENTAL
Intervention: KingVision channeled (KVC) blade
Number of subjects: 100

Group type: COMPARATOR
Intervention: KingVision non-channeled (KVNC) blade
Number of subjects: 100

Group type: COMPARATOR
Intervention: Direct laryngoscope (DL)
Number of subjects: 100
Study: 34398011

Group type: EXPERIMENTAL
Intervention: Deep neuromuscular blockade
Number of subjects: 82

Group type: COMPARATOR
Intervention: Moderate neuromuscular blockade
Number of subjects: 82
Study: 33261355

Group type: EXPERIMENTAL
Intervention: Mixed images (randomized set of neutrally or negatively arousing images)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Pure images (organized set of either all neutral or all negatively arousing images)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Mixed images
Number of subjects: 84

Group type: COMPARATOR
Intervention: Pure images
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Higher fractal dimension from EEG
Number of subjects: 84
Study: 35397138

Group type: EXPERIMENTAL
Intervention: Ticagrelor 90 mg twice daily
Number of subjects: 250

Group type: COMPARATOR
Intervention: Aspirin 81 mg
Number of subjects: 250
Study: 34290803

Group type: EXPERIMENTAL
Intervention: Maitland mobilization
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 30
Study: 32931708

Group type: EXPERIMENTAL
Intervention: bovine lactoferrin (bLF) 200 mg·(kg body mass)‐1·day‐1
Number of subjects: 335

Group type: COMPARATOR
Intervention: maltodextrin (control)
Number of subjects: 335

Group type: EXPERIMENTAL
Intervention: bovine lactoferrin (bLF)
Number of subjects: 335
Study: 33031838

Group type: COMPARATOR
Intervention: Cryotherapy
Number of subjects: 150
Study: 35549708

Group type: COMPARATOR
Intervention: Sensor-Augmented Pump (SAP)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Adaptive Zone Model Predictive Control AID
Number of subjects: 35
Study: 34533579

Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lopinavir and Ritonavir
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 32982204

Group type: EXPERIMENTAL
Intervention: Tiotropium/Olodaterol
Number of subjects: 80

Group type: COMPARATOR
Intervention: Tiotropium
Number of subjects: 80
Study: 35921506

Group type: EXPERIMENTAL
Intervention: Pramipexole (0.75 mg twice daily, n = 100)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo (n = 100)
Number of subjects: 200
Study: 33418951

Group type: EXPERIMENTAL
Intervention: Low Carbohydrate, High Fat (LCHF) diet
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Low Carbohydrate, High Fat (LCHF) diet after 2 days
Number of subjects: 14

Group type: COMPARATOR
Intervention: High Carbohydrate (HC) diet
Number of subjects: 14
Study: 35272649

Group type: EXPERIMENTAL
Intervention: Online education (1 face-to-face session + access to online education)
Number of subjects: 827

Group type: EXPERIMENTAL
Intervention: Face-to-face education only (4 separate 1-h sessions)
Number of subjects: 827

Group type: COMPARATOR
Intervention: Standard care (control)
Number of subjects: 827
Study: 33423364

Group type: EXPERIMENTAL
Intervention: Fludora® Fusion 562.5 WP-SB (target dose 225 mg AI/m2)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Clothianidin 70 WG (target dose 200 mg AI/m2)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: K-Othrine 250 WG (deltamethrin, target dose 25 mg AI/m2)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ficam VC 80 WP-SB (bendiocarb, target dose 400 mg AI/m2)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Unsprayed control
Number of subjects: 0
Study: 35291435

Group type: EXPERIMENTAL
Intervention: Atorvastatin with vitamin E (20 mg atorvastatin and 400 IU vitamin E daily for 12 weeks)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Atorvastatin with placebo (20 mg atorvastatin daily for 12 weeks)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Atorvastatin with vitamin E
Number of subjects: 30
Study: 32146550

Group type: EXPERIMENTAL
Intervention: Metformin 1000 mg three times daily (tds) in combination with carboplatin/paclitaxel
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Metformin 1000 mg tds
Number of subjects: 15
Study: 34417416

Group type: EXPERIMENTAL
Intervention: Supervised group‐based multicomponent Otago Exercise Program (OEP)
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Supervised group‐based multicomponent exercise program intervention with oral nutritional supplementation (OEP+N)
Number of subjects: 111

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 111
Study: 33988924

Group type: EXPERIMENTAL
Intervention: Paliperidone Palmitate once-monthly (PP1M)
Number of subjects: 275

Group type: COMPARATOR
Intervention: Oral Antipsychotics (OAPs)
Number of subjects: 275
Study: 32967638

Group type: EXPERIMENTAL
Intervention: mHealth support system as an addition to standard care
Number of subjects: 28

Group type: COMPARATOR
Intervention: Standard care alone
Number of subjects: 28
Study: 32716653

Group type: EXPERIMENTAL
Intervention: Online ratings from physician review websites (Healthgrades, Vitals)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Patient comments analysis
Number of subjects: 100

Group type: COMPARATOR
Intervention: Comparison with CAHPS survey
Number of subjects: 100
Study: 32894625

Group type: EXPERIMENTAL
Intervention: Standard eradication triple therapy
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 35849455

Group type: EXPERIMENTAL
Intervention: LNG 1.5 mg
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: LNG 3.0 mg
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 70
Study: 32081564

Group type: EXPERIMENTAL
Intervention: Postoperative natural killer cell activity (NKA)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Postoperative NKA in patients with negative surgical margins
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: NKA ratio (postoperative NKA/preoperative NKA) in patients with negative surgical margins
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Postoperative NKA in lower-stage PCa
Number of subjects: 51
Study: 35996355

Group type: EXPERIMENTAL
Intervention: Active ESWT (n = 20)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo ESWT (n = 20)
Number of subjects: 40
Study: 32876805

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 117

Group type: COMPARATOR
Intervention: Dexmedetomidine
Number of subjects: 117